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INTRODUCTION
Insulin-like growth factor 1 (IGF-1) and IGF-2 are also known
as somatomedin C and somatomedin A, respectively, and these
are single chain polypeptides that share amino acid sequence
homology with insulin. The insulin-like growth factor system is
formed by the peptide factors (insulin, IGF-1 and IGF-2), their
cellular receptors and the specific IGF binding proteins (classi-
cally IGFBP-1 to -6) (1). The type 1 receptor mediates most of the
biological effects of IGF-1, 2 (2). The type 2 receptor is involved
with IGF-2 regulation. The liver is the main source of the plasma
IGFs released into the circulation. However IGFs have been found
in most tissues and they appear to exert both local (organ-specific;
autocrine/paracrine) and systemic (endocrine) actions (3, 4).
IGF-1 is necessary for the normal development and mainte-
nance of the inner ear (5) and IGF-2 compensates for IGF-1 actions
during early development (6). IGF-1 knockout mice showed a sig-
nificant reduction in the size of the cochlea and cochlear ganglion
(7, 8) and so IGF-1 is an essential factor for the normal develop-
ment of the inner ear. IGF-2 appears to be more local distributed
compared with that of IGF-1 (4), and IGF-2 shows many benefi-
cial actions. IGF-2 can act as a growth factor in the teratocarci-
noma cell line by promoting overall cell survival (9). IGF-2 can
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it can be related to neuronal differentiation (11) and other regu-
lations after neurotoxic insults (12). Thus, the IGF system effi-
ciently signals to cells to grow, differentiate and survive because
the IGF system can prevent apoptosis by activation of phospho-
inositide 3-kinase (PI3K) (13) and increasing the level of prolif-
erating cell nuclear antigen (PCNA) (14). IGFs are important
for regeneration/repair in the mammalian labyrinth (15). IGFs
are also accepted as neurotrophic factors, and they are associat-
ed with the therapeutic potential to alleviate neurodegerative
disease (1, 16). 
Salicylate toxicity presents a unique pattern of auditory dys-
function that consists of reversible hearing loss and tinnitus. In
humans, high dosages of salicylate induce a moderate degree of
hearing loss and tinnitus, and salicylate’s effect on the hearing
threshold and volume of tinnitus are dose-dependent (17). In
our previous study, a threshold shift of 30 dB can be induced
after a few hours and this returns to normal after 1-3 days in a
mouse model of salicylate intoxication (18). A concurrent exper-
iment that used a microarray analysis revealed IGF-2 to be a
prominent factor in salicylate ototoxicity (18). The purpose of
this current study was to identify the expressions of IGF-1 and
IGF-2 in a murine model of salicylate ototoxicity, which is a typ-
ical reversible hearing loss model. 
MATERIALS AND METHODS
Preparation of samples
Thirty male BALB/c adult mice (mean body weight, 40.4 g) with
normal hearing were used in this study. Ten male BALB/c adult
mice with normal hearing, as was initially assessed by ABR mea-
surement, were used for the normal controls. The mice were anes-
thetized with rodent cocktail (Ketamine 50 mg/kg and Rompun 5
mg/kg). Sodium salicylate (Sigma Chemical Co., St. Louis, MO,
USA) was dissolved in 0.9% sodium chloride (400 mg/kg) and
this was given as intra-peritoneal injections to the mice. The ABR
thresholds were measured by broad band clicks at 3 hours and
72 hours after an injection of sodium salicylate. The ABR thresh-
olds were measured with a Navigator Pro Diagnostic ABR/ASSR
system (Bio-logic Systems Co., Mundelein, IL, USA). An approx-
imate 30 dB threshold shift was achieved at 3 hours after the
sodium salicylate injection (the salicylate 3 hours group), and
then 10 mice were sacrificed. The temporal bones were imme-
diately removed and the bony cochleae were removed under a
stereoscope and immediately frozen at -70℃ for later use to
synthesize the cDNA. Return to the normal threshold, as mea-
sured by the ABR, was observed in another 10 mice at 72 hours
after the sodium salicylate injection (the salicylate 72 hours
group). Their cochleae were removed under a stereoscope and
immediately frozen at -70℃ until further use for the salicylate
72 hours group.
HEI-OC1 cell culture 
Establishment of the HEI-OC1 cell line has been facilitated by
the development of a transgenic mouse, the Immortomouse,
which harbors a temperature-sensitive mutant of the SV40 large
T antigen gene. HEI-OC1 cells express several molecular mark-
ers that are characteristic of the organ of Corti sensory cells, and
HEI-OC1 cells are extremely sensitive to ototoxic drugs (19).
Therefore, the HEI-OC1 cell line can be a useful model to study
ototoxic drugs such as cisplatin and salicylate. The HEI-OC1 cell
line was kindly provided by F. Kalinec (House Ear Institute, Los
Angeles, CA, USA). The cells used in this study were maintained
in DMEM with 10% FBS at 33℃ under a 10% CO2 in air atmos-
phere. 
Semi-quantitative RT- PCR 
The expression of each target mRNA was confirmed by semi-
quantitative reverse transcription polymerase chain reaction (RT-
PCR). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
as a housekeeping gene, was also used as an internal control in
the PCR protocol. The PCR cycle consisted of: 1) 94℃ for 30
seconds, 2) 52-62℃ for 30 seconds, and 3) 72℃ for 1 minute
30 seconds. This protocol was repeated for 33 cycles, and a control
PCR reaction, which involved taq polymerase and the primer
combination, but no template, was used as a negative PCR con-
trol. The PCR products were separated on 1.5% agarose gel,
and they were visualized by ethidium bromide staining. The
Polaroid photographs were optically scanned and analyzed with
the National Institute of Health Image Software ver.1.6 and the
available gel macros. 
MTT assay
The uptake and conversion of 3-(4, 5-Dimethylthiazol-2-yl)-2,
5-diphenyl-tetrazdiumbromide (MTT, Sigma) to crystals of dark
violet formazan is dependent on the mitochondria activity. Cell
viability was measured using the MTT assay and this was
expressed as a percentage of the untreated control cell samples.
The dose-dependent or time-dependent effects of salicylate
were measured by performing MTT assay on the HEI-OC1 cell
cultures. The cells were treated with 1, 5, 10, or 20 mM salicy-
late for 24 (circle), 48 (square) and 72 (triangle) hours, and with
salicylate (at 20 mM) for 0, 3, 6, 12, 24, 48, and 72 hours. For
MTT assay, 50 mL of MTT solution (0.25 mg) was added to 0.5
mL of the cell suspension, and the plates were then incubated
for 4 hours at 33℃ in 10% CO2. The insoluble formazan crys-
tals were centrifuged, and the pellets were dissolved by the addi-
tion of DMSO (500 mL/well). The optical density was measured
at 570 nm with using a microplate reader (Spectra Max, Molecular
Devices, Sunnyvale, CA, USA).
Hoechst 33258 staining
The loss of cell viability was determined by evaluating the nuclear
morphology with performing Hoechst 33258 staining. The HEI-
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(control) or with salicylate at 10 mM and 20 mM for 24 hours.
After fixation with 4% paraformaldehyde for 10 minutes at
room temperature, the cells were washed twice with phosphate-
buffered saline (PBS) and incubated with 10 mg/mL Hoechst
33258 (Sigma) for 10 minutes at room temperature in a dark
room. After two washes, the condensed and fragmented nuclei
were observed under an inverted fluorescence microscope
(BX61, Olympus, Tokyo, Japan).
Confocal immunofluorescence imaging
For the immunohistochemical study, the tissue samples were
embedded, cryosectioned and then stored at -80℃ prior to use.
The sections were air dried, rehydrated in PBS and blocked with
normal horse serum. The endogenous peroxidase was inactivat-
ed by incubation with 3% hydrogen peroxidase for 15 minutes
at room temperature. After incubation with the mouse mono-
clonal IGF-1 and 2 antibody at a dilution of 1:500 overnight at
room temperature, the biotinylated secondary antibody was
applied, followed by the avidin-biotin-peroxidase complex. The
color was developed using 3,3′ -diaminobenzidine. The cells
were photographed and analyzed with a confocal microscope
(Carl Zeiss, MicroImaging Inc., Thornwood, NY, USA) and a
Zeiss LSM Image Browser. 
Western blotting
For Western blot analysis, equal amounts of the total protein
were separated on 7.5% sodium dodecyl sulfate-polyacrylamide
gels and the proteins were transferred to immobilon (Millipore,
Bedford, MA, USA). The blots were blocked for 1 hour at room
temperature with PBS containing 1% skim milk and then the
blots were incubated with anti-IGF-1 and 2 antibodies for
overnight at room temperature. The biotinylated secondary
antibody was applied and this was followed by the avidin-
biotin-peroxidase complex. The color was developed using
3,3′ -diaminobenzidine. 
RESULTS
The IGFs’ mRNA expressions were increased in the salicylate
ototoxicity mice. Semi-quantitative RT-PCR analysis confirmed
that the IGFs’ mRNA expressions were significantly enhanced
in the salicylate ototoxicity groups as compared with that of the
normal control group (Fig. 1A). The ratio of the expression lev-
els, as seen on the images of RT-PCR and as measured by den-
sitometry, was significantly higher in the salicylate groups (and
especially in the salicylate 3 hours group) than that of the nor-
mal control group (Fig. 1B, C). One-way ANOVA indicated that
the difference in the mean fold induction in the salicylate 3 hours
group was significant as compared with that of the mean fold induc-
tion of the normal control group (P<0.05).
Cell viability was decreased in a dose- and time-dependent
manner. The viability of the HEI-OC1 cell cultures was decreased
in a dose-dependent (Fig. 2A) and time-dependent (Fig. 2B) man-
ner in the mice with salicylate ototoxicity. The nuclei of the nor-
mal control cells were observed as round-shaped with homoge-
nous staining (Fig. 3A). Compared with the normal control nuclei,
the 10 mM and 20 mM salicylate induced characteristic apoptot-
ic morphology of the nuclei showed heterogeneous staining con-
densation and fragmentation (Fig. 3B, C). These changes were
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Fig. 1. Semi-quantitative reverse transcription polymerase chain reac-
tion (RT-PCR) analysis confirmed that the insulin-like growth factors
(IGFs)’ mRNA expressions were significantly enhanced in the salicy-
late (sal) ototoxicity groups as compared with that of the normal con-
trol group (A). The ratio of the expression levels on the image of the
RT-PCR and as measured by densitometry was significantly higher in
the salicylate group (and especially the salicylate 3 hours group) as
compared to that of the normal control group (B, IGF-1; C, IGF-2).
*P<0.05 compared with the control group.
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the fact that salicylate induced apoptotic cellular changes occurred
in the HEI-OC1 cell line.
Confocal immunofluorescence imaging IGF-1 and 2 were high-
ly expressed in the stria vascularis at 72 hours after an injection
of sodium salicylate, as compared with that of the normal con-
trol group and the salicylate 72 hours group (Fig. 4). The stria
vascularis is a vascular-rich area in the cochlea, and systemic
IGFs can be expressed in this region.
Western blotting
The expression of IGF-1 and 2 proteins was increased in the sali-
cylate ototoxicity groups as compared with that of the normal
control group. In the in-vivo condition, the expression of IGFs
was higher in the salicylate ototoxicity groups as compared with
that of the normal control group, and especially in the salicylate
3 hours group, and there were similar patterns on both RT-PCR
and Western blotting. In the in-vitro condition, the expressions
of IGFs were slightly increased compared with that of the nor-
mal control (Fig. 5). 
DISCUSSION
This study originated from our previous study, which showed
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Fig. 2. Cytotoxic effect of salicylate on the HEI-OC1 cell cultures. Cell viability was measured using the MTT assay and this was expressed as a
percentage of the untreated control cell samples. Dose-dependent (A) or time-dependent (B) effects of salicylate on the HEI-OC1 cell cultures.
The cells treated with 1, 5, 10, or 20 mM salicylate for 24 ( ), 48 ( ), and 72 ( ) hours (A), and with salicylate (at 20 mM) for 0, 3, 6, 12, 24, 48,
and 72 hours (B). The values are the mean±SE of the data. 
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Fig. 3. Hoechst 33258 staining of the salicylate-treated HEI-OC1 cell cultures. The HEI-OC1 cell cultures were treated without salicylate for 24
hours (A), or with salicylate at 10 mM (B) and 20 mM (C) for 24 hours, and they were examined under a light microscope. The nuclei of the nor-
mal control cells were shown as round-shaped with homogenous staining (A). However, the 10 mM and 20 mM salicylate treatment induced
characteristic apoptotic morphology nuclei with heterogeneous staining, condensation and fragmentation (B, C).
10 mm 10 mm 10 mm A B Chigh expressions of IGFs on the microarray analysis of mice with
salicylate ototoxicity (18). Hearing measurement in the salicy-
late-intoxicated mouse (ABR threshold measurements by broad-
band clicks) showed a maximal threshold shift of 33 dB at 3
hours (33±6.3 dB) after salicylate administration, and these
changes were reversible after 72 hours (12.5±2.6 dB) in our
previous study (18). Salicylate ototoxicity can be an interesting
model of reversible hearing loss for both animals and human. 
In this study, the IGF-1 and IGF-2 mRNA expressions were
observed and especially in the salicylate 3 hours group, which
Im GJ et al.: IGFs Expression in Salicylate Ototoxicity 119
Fig. 4. Confocal immunofluorescence imaging of the insulin-like growth factors (IGFs) in salicylate ototoxicity. The IGFs expressions were non-
specific in the normal control group (A, B). IGF-1 and 2 were highly expressed in the stria vascularis (arrow) 3 hours after an injection of sodium
salicylate, as compared with that of the normal control group and the salicylate 72 hours group (C, D). Decreased IGF expressions were
observed in the salicylate 72 hours group, which is the time of returning to normal hearing (E, F). Scale bars is 100 mm. 
Control
IGF-1 IGF-2
Salicylate 3 hours
Salicylate 72 hours
A B
C D
E Fis the time of showing the maximal toxic effect of salicylate.
Otherwise, the IGFs expressions were less in both the control
group and the salicylate 72 hours group, which is the time the
hearing returns to normal. This observation shows that IGFs
play some role in salicylate ototoxicity. 
On the western blotting, the IGFs protein expression was
increased, and especially in the 3 hours group of the in-vivo
study. On the confocal immunofluorescence imaging, IGF-1
and IGF-2 were highly expressed in the stria vascularis, which
is a vascular-rich area in the cochlea. This observation was pre-
dictable because IGFs are mainly produced systemically and
they are supplied to the whole body by the blood system. These
results show that systemic IGFs’ actions may be critical to pre-
vent permanent damages induced by the salicylate in the in-
vivo condition. Otherwise, the local production and action of
IGFs (autocrine/paracrine) may be possible in the cochlea because
the expressions of IGFs proteins were increased in both the in-
vivo and in-vitro conditions. The IGFs system can work in both
the in-vitro and in-vivo conditions in mice with salicylate ototoxi-
city. However, the point is that the systemic IGFs’ actions can be
a main portion in the IGF system of the cochlea, which is sup-
ported by the fact that the increment of IGF protein was more
prominent, and especially in the 3 hours group, in the in-vivo
study. Thus, IGFs can protect the cochlear auditory cells from
ototoxic insults in the in-vivo condition, and the hearing thresh-
old change was reversible and little cellular damage occurred in
the salicylate-intoxicated mice (17, 18). Only the local actions
of IGFs can not cause complete recovery of cellular damage,
which was shown by MTT assay in the in-vitro study. We also
suggest that the cellular damage induced by salicylate may be
related to apoptosis because Hoechst 33258 staining revealed
the apoptotic changes induced by salicylate (20). 
We suggest that there are some protective mechanisms in sal-
icylate ototoxicity, and the IGF system may play a role in these
protective mechanisms, and especially in the in-vivo condition.
In the cochlea, the IGF system may have both local (autocrine/
paracrine) and systemic (endocrine) effects. The systemic action
of IGFs may be more powerful than the local effects of IGFs, and
the systemic action of IGFs can prevent the cochlea auditory
cells from permanent damage induced by salicylate. In the future,
an iatrogenic supply of IGFs may improve the cellular viability
and cochlear/neuronal survival in salicylate intoxicated animals,
and this requires further studies. Obviously, it is of great impor-
tance that the therapeutic value of IGFs in human should be
evaluated, and especially in the cochlea, neurons and brain.
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